Decision Diagnostics Corp (DECN)

[GASTON3]

Bottom Line
With the spread of the coronavirus showing no signs of slowing down, Decision diagnostics has on its hands a huge opportunity. Demand for coronavirus test kit should continue to spike as governments around the world race against time to contain the pandemic.

Likewise, companies with products able to enable the testing stand to reap big until an ideal vaccine for the virus comes into being. That said, Decision Diagnostics should be able to generate significant returns on selling more than 1 million GenViro test kit.

Similarly, the stock looks set to continue powering higher as investors come to terms with the huge opportunity up for grabs.